Global and China Sulfasalazine Market Insights, Forecast to 2027

Sulfasalazine is a sulfanilamide antibiotic.It is an oral sulfonamide drug that is not easy to be absorbed. The absorbed part is decomposed into 5-amino salicylic acid and sulfonamide pyridine under the action of intestinal microorganisms.5-aminosalicylic acid stays in the intestinal wall for a long time after complexing with the connective tissue of the intestinal wall, which plays an antibacterial and anti-inflammatory role and plays an immunosuppressive role, such as reducing escherichia coli and clostridium difficile, and inhibiting the synthesis of prostaglanin and other inflammatory mediators, leukotrienes.Therefore, it is believed that the main component of this product is 5-aminosalicylic acid.Sulfamopyridine produced by the decomposition of this product showed weak antibacterial effect on intestinal flora.

Market Analysis and Insights: Global and China Sulfasalazine Market
This report focuses on global and China Sulfasalazine market.
In 2020, the global Sulfasalazine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Sulfasalazine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Sulfasalazine Scope and Market Size
Sulfasalazine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Sulfasalazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Sulfasalazine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Enteric Sugar Coated Tablet
Film-Coated Tablet
Other

Segment by Application
Crohn's Disease
Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
Ankylosing Spondylitis
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Crescent Pharma Limited
Pfizer
Saaz-DS
KRKA
Vintage
Qualitest
NPS Medicinewise
Kamp Medicine
Hubei Wudang
Hebei Yinengpu
Shanxi Wanshou
Fujian Fukang
Guangzhou Huahai
WATSON LABS
Pharmacia & Upjohn
Chongqing Dikang
Shanghai Xinyi Tianping Pharmaceutical